Related references
Note: Only part of the references are listed.Gallic acid, a phenolic acid, hinders the progression of prostate cancer by inhibition of histone deacetylase 1 and 2 expression
Yin-Gi Jang et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2020)
Gallic Acid Inhibits Bladder Cancer T24 Cell Progression Through Mitochondrial Dysfunction and PI3K/Akt/NF-κB Signaling Suppression
Maolin Zeng et al.
FRONTIERS IN PHARMACOLOGY (2020)
Effect of Gallic acid in potentiating chemotherapeutic effect of Paclitaxel in HeLa cervical cancer cells
Nora M. Aborehab et al.
CANCER CELL INTERNATIONAL (2019)
Oleuropein-Induced Apoptosis Is Mediated by Mitochondrial Glyoxalase 2 in NSCLC A549 Cells: A Mechanistic Inside and a Possible Novel Nonenzymatic Role for an Ancient Enzyme
Cinzia Antognelli et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Icariin ameliorates cisplatin-induced cytotoxicity in human embryonic kidney 293 cells by suppressing ROS-mediated PI3K/Akt pathway
Yan-dan Zhou et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Gallic acid and curcumin induce cytotoxicity and apoptosis in human breast cancer cell MDA-MB-231
Hassan Moghtaderi et al.
BIOIMPACTS (2018)
Modeling the response of a tumor-suppressive network to mitogenic and oncogenic signals
Xinyu Tian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
GSK3β-dependent cyclin D1 and cyclin E1 degradation is indispensable for NVP-BEZ235 induced G0/G1 arrest in neuroblastoma cells
Shan-Ling Liu et al.
CELL CYCLE (2017)
Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination
Jason S. L. Yu et al.
DEVELOPMENT (2016)
Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway
Ruixuan Wang et al.
ONCOLOGY REPORTS (2016)
Non-small cell lung cancer: current treatment and future advances
Cecilia Zappa et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
Non-small-cell lung cancer
Cesare Gridelli et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Medicinal importance of gallic acid and its ester derivatives: a patent review
Sneha Choubey et al.
PHARMACEUTICAL PATENT ANALYST (2015)
Gallic acid: a versatile antioxidant with promising therapeutic and industrial applications
Bharti Badhani et al.
RSC ADVANCES (2015)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Targeting the PI3K/AKT/mTOR pathway: potential for lung cancer treatment
Haiying Cheng et al.
LUNG CANCER MANAGEMENT (2014)
Gallic acid: Molecular rival of cancer
Sharad Verma et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2013)
Alkyl esters of gallic acid as anticancer agents: A review
Claudriana Locatelli et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Gallic acid reduces cell viability, proliferation, invasion and angiogenesis in human cervical cancer cells
Bing Zhao et al.
ONCOLOGY LETTERS (2013)
Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation
Maria Vinci et al.
BMC BIOLOGY (2012)
Gallic Acid Induces the Apoptosis of Human Osteosarcoma Cells In Vitro and In Vivo via the Regulation of Mitogen-Activated Protein Kinase Pathways
Cheng-zhen Liang et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2012)
Anticancer property of gallic acid in A549, a human lung adenocarcinoma cell line, and possible mechanisms
Dharmendra K. Maurya et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2011)
Gallic acid-induced lung cancer cell death is accompanied by ROS increase and glutathione depletion
Bo Ra You et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways
Haibo Mou et al.
TOXICOLOGY IN VITRO (2011)
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
Ana-Maria Florea et al.
Cancers (2011)
Targeting Apoptotic Signaling Pathways in Human Lung Cancer
S. W. Han et al.
CURRENT CANCER DRUG TARGETS (2010)
Gallic acid suppresses cell viability, proliferation, invasion and angiogenesis in human glioma cells
Yong Lu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Gallic acid induces apoptosis in A375.S2 human melanoma cells through caspase-dependent and -independent pathways
Chyi Lo et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2010)
Inhibitors of phosphatidylinositol-3-kinase in cancer therapy
Nathan T. Ihle et al.
MOLECULAR ASPECTS OF MEDICINE (2010)
Anti-Neoplastic Effects of Gallic Acid, a Major Component of Toona sinensis Leaf Extract, on Oral Squamous Carcinoma Cells
Yi-Chen Chia et al.
MOLECULES (2010)
Aberration of the PI3K/AKT/mTOR signaling in epithelial ovarian cancer and its implication in cisplatin-based chemotherapy
Hai-Yan Zhang et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2009)
Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats
M. I. Yousef et al.
FOOD AND CHEMICAL TOXICOLOGY (2009)
Gallic Acid Induces Apoptosis via Caspase-3 and Mitochondrion-Dependent Pathways in Vitro and Suppresses Lung Xenograft Tumor Growth in Vivo
Bin-Chuan Ji et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2009)
Inhibition of PI3K-AKT-mTOR Signaling Sensitizes Melanoma Cells to Cisplatin and Temozolomide
Tobias Sinnberg et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Lung Adjuvant Cisplatin Evaluation: A pooled analysis by the LACE collaborative group
Jean-Pierre Pignon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Regulation of p73-mediated apoptosis by c-Jun N-terminal kinase
Emma V. Jones et al.
BIOCHEMICAL JOURNAL (2007)
Lead-induced apoptosis in PC 12 cells: Involvement of p53, Bcl-2 family and caspase-3
Jin Xu et al.
TOXICOLOGY LETTERS (2006)
The p53-Bcl-2 connection
M. T. Hemann et al.
CELL DEATH AND DIFFERENTIATION (2006)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
Cyclins and cdks in development and cancer: a perspective
A Deshpande et al.
ONCOGENE (2005)
PI3K/Akt signalling pathway and cancer
JAF Vara et al.
CANCER TREATMENT REVIEWS (2004)
Platinum-based chemotherapy in metastatic breast cancer: current status
MP Decatris et al.
CANCER TREATMENT REVIEWS (2004)
G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells
N Gao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy
F Chang et al.
LEUKEMIA (2003)
Assessment of the no-observed-adverse-effect level (NOAEL) of gallic acid in mice
K Rajalakshmi et al.
FOOD AND CHEMICAL TOXICOLOGY (2001)
Catalase contents in cells determine sensitivity to the apoptosis inducer gallic acid
K Isuzugawa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2001)
Proliferation, cell cycle and apoptosis in cancer
GI Evan et al.
NATURE (2001)
Requirement for ERK activation in cisplatin-induced apoptosis
XT Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
